187 related articles for article (PubMed ID: 19663135)
1. Use of angiotensin receptor blockers after angioedema with an angiotensin-converting enzyme inhibitor.
Haymore BR; DeZee KJ
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):83-4. PubMed ID: 19663135
[No Abstract] [Full Text] [Related]
2. [ Therapy of patients at high risk for vascular events: telmisartan, ramipril or a combination? ].
Düsing R; Nitschmann S
Internist (Berl); 2008 Sep; 49(9):1137-40. PubMed ID: 18665340
[No Abstract] [Full Text] [Related]
3. Early and effective treatment of hypertension: ONTARGET provides some answers.
Cardiovasc J Afr; 2009; 20(5):323. PubMed ID: 19907811
[No Abstract] [Full Text] [Related]
4. Telmisartan, ramipril, or both in patients at high risk of vascular events.
Messerli FH; Bangalore S; Ram VS
N Engl J Med; 2008 Jul; 359(4):426-7; author reply 427. PubMed ID: 18655247
[No Abstract] [Full Text] [Related]
5. ONTARGET should not be over interpreted.
Abutaleb N
Nephrol Dial Transplant; 2010 Jan; 25(1):44-7. PubMed ID: 19934088
[No Abstract] [Full Text] [Related]
6. Is therapy of people with chronic kidney disease ONTARGET?
Mann JF; Tobe S; Teo KK; Yusuf S
Nephrol Dial Transplant; 2010 Jan; 25(1):42-4. PubMed ID: 19854846
[No Abstract] [Full Text] [Related]
7. Telmisartan, ramipril, or both in patients at high risk for vascular events.
; Yusuf S; Teo KK; Pogue J; Dyal L; Copland I; Schumacher H; Dagenais G; Sleight P; Anderson C
N Engl J Med; 2008 Apr; 358(15):1547-59. PubMed ID: 18378520
[TBL] [Abstract][Full Text] [Related]
8. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
Middeke M
Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
[No Abstract] [Full Text] [Related]
9. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
Serebruany VL; Atar D; Hanley DF
Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
[No Abstract] [Full Text] [Related]
10. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
[No Abstract] [Full Text] [Related]
11. Proteinuria: Is the ONTARGET renal substudy actually off target?
Ruggenenti P; Remuzzi G
Nat Rev Nephrol; 2009 Aug; 5(8):436-7. PubMed ID: 19639016
[No Abstract] [Full Text] [Related]
12. Angioedema: 6 years experience with fourteen cases.
Taki M; Watanabe H; Hasegawa T; Bamba H; Shimada T; Hisa Y
Auris Nasus Larynx; 2010 Apr; 37(2):199-204. PubMed ID: 19709832
[TBL] [Abstract][Full Text] [Related]
13. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers].
Rosenborg S
Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078
[No Abstract] [Full Text] [Related]
14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
15. [New studies on hypertension of great significance to clinical practice. Also very old persons benefit from blood pressure reduction].
Nilsson PM
Lakartidningen; 2008 May 7-13; 105(19):1382-4. PubMed ID: 18574975
[No Abstract] [Full Text] [Related]
16. ARBs for cardiovascular and renal protection in high-risk patients.
Aalbers J
Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
[No Abstract] [Full Text] [Related]
17. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?
Howes LG; Tran D
Drug Saf; 2002; 25(2):73-6. PubMed ID: 11888349
[TBL] [Abstract][Full Text] [Related]
18. Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review.
Kalra A; Cooley C; Palaniswamy C; Kalra A; Zanotti-Cavazzoni SL
Am J Ther; 2012 Nov; 19(6):e189-92. PubMed ID: 20838200
[TBL] [Abstract][Full Text] [Related]
19. Angioedema induced by angiotensin II blocker telmisartan.
Borazan A; Ustün H; Yilmaz A
Allergy; 2003 May; 58(5):454. PubMed ID: 12752339
[No Abstract] [Full Text] [Related]
20. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
Beavers CJ; Dunn SP; Macaulay TE
Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
